tradmap

PODD Financials Insulet Corporation

15 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings — with a computed, factual read of the trend. Updated Overview →

Growth & profitability

  • Revenue has grown 24.5% per year over the past 5 years.
  • Net income has grown faster than revenue (105.2% vs 24.5% per year).
  • Operating margin has expanded, at 17.5% in the latest year.

Financial health

  • Total debt has grown slower than revenue (19.9% vs 24.5% per year).
  • Operating income covered interest expense 8.0× in the latest year.
Revenue & net income
-$74M $1B $3B $0 2011 2013 2015 2017 2019 2021 2023 2025
RevenueNet income
Margins (gross / operating / net)
-28% 22% 72% 0% 2011 2013 2015 2017 2019 2021 2023 2025
GrossOperatingNet
Return on equity & assets (ROE / ROA)
-216% -91% 35% 0% 2011 2013 2015 2017 2019 2021 2023 2025
ROEROA
Free cash flow (CFO − capex)
-$180M $99M $378M $0 2011 2013 2015 2017 2019 2021 2023 2025
Free cash flow
Cash vs total debt
$0 $701M $1B 2011 2013 2015 2017 2019 2021 2023 2025
CashTotal debt
Cash flow: operating / investing / financing
-$595M $5M $606M $0 2011 2013 2015 2017 2019 2021 2023 2025
OperatingInvestingFinancing

Key annual figures

FYRevenueNet incomeGross MOp MROEROAFCFTotal debtCash
2025 $2.7B $247M 71.6% 17.5% 16.3% 7.7% $378M $716M
2024 $2.1B $418M 69.8% 14.9% 34.5% 13.5% $305M $953M
2023 $1.7B $206M 68.3% 13.0% 28.2% 8.0% $70M $704M
2022 $1.3B $5M 61.7% 2.9% 1.0% 0.2% -$4M $1.4B $690M
2021 $1.1B $17M 68.4% 11.5% 3.0% 0.8% -$180M $1.3B $806M
2020 $904M $7M 64.4% 5.7% 1.1% 0.4% -$45M $1.1B $922M
2019 $12M 15.3% 1.0% -$65M $888M $214M
2018 $3M 1.6% 0.4% -$122M $592M $114M
2017 $464M -$27M 59.8% -1.6% -16.9% -3.3% -$33M $566M $273M
2016 $367M -$29M 57.5% -2.9% -45.8% -6.3% -$6M $333M $137M
2015 $264M -$74M 50.5% -18.5% -215.9% -26.7% -$23M $172M $123M
2014 $231M -$52M 55.0% -3.8% -61.4% -17.3% -$3M $164M $151M
2013 -$45M -36.1% -15.6% -$4M $114M
2012 -$52M -117.4% -26.2% -$40M $118M
2011 -$46M -55.4% -20.7% -$37M $109M

Valuation over time

How the market has priced PODD against its own fundamentals since 2023-03 — each month-end's share price set against the most recent annual filing, so the multiple moves as price runs ahead of (or behind) earnings. Split-adjusted.

Price / earnings (P/E)
0.0 2404.6 4809.3 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/E
Price / sales (P/S)
0.0 8.5 16.9 Mar '23 Sep '23 Mar '24 Sep '24 Mar '25 Sep '25 Mar '26 Sep '26
P/S

Frequently asked questions

Is PODD growing its revenue and profit?

Over the past 5 years, Insulet Corporation's revenue has grown 24.5% per year, and net income grown 105.2% per year. These are computed facts, not advice.

How much debt does PODD have?

As of FY2025, Insulet Corporation reported — of total debt against $716M of cash; operating income covered interest expense 8.0×.

What is PODD's profit margin?

In FY2025, gross margin was 71.6%, operating margin 17.5%, and net margin 9.1%.

What is PODD's P/E ratio?

As of Sep '26, Insulet Corporation traded at a price-to-earnings ratio of about 42.3× (market cap ÷ latest annual net income). The valuation charts above show how its P/E, P/S have moved with the share price. These are computed facts, not advice.

Where does this data come from?

All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.

Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.